These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32122645)

  • 1. Advanced neuroimaging: A window into the neural correlates of fetal programming related to prenatal exposure to maternal depression and SSRIs.
    Rotem-Kohavi N; Williams LJ; Oberlander TF
    Semin Perinatol; 2020 Apr; 44(3):151223. PubMed ID: 32122645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hub distribution of the brain functional networks of newborns prenatally exposed to maternal depression and SSRI antidepressants.
    Rotem-Kohavi N; Williams LJ; Muller AM; Abdi H; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Depress Anxiety; 2019 Aug; 36(8):753-765. PubMed ID: 31066992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study.
    Jha SC; Meltzer-Brody S; Steiner RJ; Cornea E; Woolson S; Ahn M; Verde AR; Hamer RM; Zhu H; Styner M; Gilmore JH; Knickmeyer RC
    Psychiatry Res Neuroimaging; 2016 Jul; 253():43-53. PubMed ID: 27254086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in Neurodevelopmental Outcomes in Children with Prenatal SSRI Antidepressant Exposure.
    Rotem-Kohavi N; Oberlander TF
    Birth Defects Res; 2017 Jul; 109(12):909-923. PubMed ID: 28714603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal infant EEG bursts are altered by prenatal maternal depression and serotonin selective reuptake inhibitor use.
    Grieve PG; Fifer WP; Cousy NP; Monk CE; Stark RI; Gingrich JA; Myers MM
    Clin Neurophysiol; 2019 Nov; 130(11):2019-2025. PubMed ID: 31539768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal serotonin signaling: setting pathways for early childhood development and behavior.
    Oberlander TF
    J Adolesc Health; 2012 Aug; 51(2 Suppl):S9-16. PubMed ID: 22794534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
    Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
    JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal SSRI exposure: Effects on later child development.
    Hermansen TK; Melinder A
    Child Neuropsychol; 2015; 21(5):543-69. PubMed ID: 25089614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
    Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
    Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review.
    Andalib S; Emamhadi MR; Yousefzadeh-Chabok S; Shakouri SK; Høilund-Carlsen PF; Vafaee MS; Michel TM
    Eur Psychiatry; 2017 Sep; 45():161-166. PubMed ID: 28917161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.
    Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM
    Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal exposure to antidepressants is associated with altered brain development in very preterm-born neonates.
    Podrebarac SK; Duerden EG; Chau V; Grunau RE; Synnes A; Oberlander TF; Miller SP
    Neuroscience; 2017 Feb; 342():252-262. PubMed ID: 27890829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.
    Harrington RA; Lee LC; Crum RM; Zimmerman AW; Hertz-Picciotto I
    Autism Res; 2013 Jun; 6(3):149-68. PubMed ID: 23495208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal selective serotonin reuptake inhibitor exposure: impact on brain development and neural plasticity.
    Pawluski JL
    Neuroendocrinology; 2012; 95(1):39-46. PubMed ID: 21893935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.